<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>Business Recorder - News</title>
    <link>https://www.brecorder.com/</link>
    <description>Business Recorder</description>
    <language>en-Us</language>
    <copyright>Copyright 2026</copyright>
    <pubDate>Thu, 13 Aug 2026 23:40:30 +0500</pubDate>
    <lastBuildDate>Thu, 13 Aug 2026 23:40:30 +0500</lastBuildDate>
    <ttl>60</ttl>
    <item xmlns:default="http://purl.org/rss/1.0/modules/content/">
      <title>Abbott Labs declares 30pc dividend</title>
      <link>https://www.brecorder.com/news/4102/abbott-labs-declares-30pc-dividend</link>
      <description>&lt;p class="MsoNormal"&gt;&lt;img style="margin-right: 10px; margin-bottom: 10px; float: left;" alt=" " src="https://i.brecorder.com/images/stories/coin.jpg" width="400" height="293" /&gt;KARACHI: Abbott Laboratories Ltd posted a record profit after tax of Rs 1.176 billion for 13 months ending December 31, 2010 and declared a final cash dividend of Rs 3 per share.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;According to financial results of the pharmaceutical company despatched to Karachi Stock Exchange here on Tuesday, the profit before tax has surged to Rs 1.741 billion as earning per share also improved to Rs 12.02 compared to Rs 6.22 in the same period last year.&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;Center /&gt;&lt;b&gt;&lt;i&gt;Copyright APP (Associated Press of Pakistan), 2011&lt;/b&gt;&lt;/i&gt;&lt;/center&gt;&lt;/p&gt;
</description>
      <content:encoded xmlns="http://purl.org/rss/1.0/modules/content/"><![CDATA[<p class="MsoNormal"><img style="margin-right: 10px; margin-bottom: 10px; float: left;" alt=" " src="https://i.brecorder.com/images/stories/coin.jpg" width="400" height="293" />KARACHI: Abbott Laboratories Ltd posted a record profit after tax of Rs 1.176 billion for 13 months ending December 31, 2010 and declared a final cash dividend of Rs 3 per share.</p>
<p class="MsoNormal">According to financial results of the pharmaceutical company despatched to Karachi Stock Exchange here on Tuesday, the profit before tax has surged to Rs 1.741 billion as earning per share also improved to Rs 12.02 compared to Rs 6.22 in the same period last year.</p>
<p class="MsoNormal"><Center /><b><i>Copyright APP (Associated Press of Pakistan), 2011</b></i></center></p>
]]></content:encoded>
      <category/>
      <guid>https://www.brecorder.com/news/4102</guid>
      <pubDate>Tue, 22 Feb 2011 14:45:10 +0500</pubDate>
      <author>none@none.com (Imad Uddin)</author>
    </item>
  </channel>
</rss>
